You are here

Chewable Birth Control Pill Now Available

ROCKAWAY, N.J., Dec 07, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott (Nasdaq: WCRX) announced today the availability of the first birth control pill that offers women the option of chewing their daily tablet, called Femcon Fe.

As the first and only FDA-approved chewable birth control pill, Femcon Fe* is indicated for the prevention of pregnancy. The chewable version is also designed to provide a convenient, new option for women "on-the-go" taking oral contraceptives. Additionally, the active ingredients and doses in Femcon Fe provide effective cycle control and may be a good choice for women who are experiencing breakthrough bleeding with their current oral contraceptive.

"Research has shown that compliance still impacts oral contraceptive failure rates, and anything we can do to make it easier for our patients to maintain a daily regimen is a notable advancement," said Laurent Delli-Bovi, MD, Medical Director, Women's Health Services at Chestnut Hill Family Planning Facility in Boston, Massachusetts. "We're excited to be able to offer a chewable formulation to patients looking for convenience or to those who may be experiencing problems on other pills, such as breakthrough bleeding."

When taken correctly, oral contraceptives have a failure rate of less than one percent per year. However, studies show that 47 percent of women miss one or more pills per month and missing pills can increase the risk of pregnancy.

"Women who rely on the birth control pill tend to lead busy lives and have less time," said Roger Boissonneault, Chief Executive Officer of Warner Chilcott, the company that markets Femcon Fe in the United States. "We wanted to offer women a convenient, easy-to-use option for those "on-the-go" with the same reliability as the traditional swallowed pill."

Femcon Fe contains the same active ingredients as found in other combination oral contraceptives -- a progestin, norethindrone 0.4 mg, and an estrogen, ethinyl estradiol 35 mcg. Available in a 28-day regimen, each blister-package of Femcon Fe contains 21 round white tablets with norethindrone and ethinyl estradiol, followed by seven "reminder" brown (inactive) tablets to complete a four-week-cycle. The reminder tablets also contain 75 mg of ferrous fumarate (iron). The pill may be chewed, followed by a full glass of liquid, or swallowed whole.

Important Safety Information about Femcon Fe
Femcon Fe potential side effects are similar to those seen with other progestin/estrogen combination oral contraceptives. Serious risks include an increased risk of blood clots, heart attack and stroke. Cigarette smoking by women, especially over age 35, increases the risk of serious cardiovascular side effects from use of oral contraceptives. Oral contraceptives do not protect against HIV infection (AIDS) or other sexually transmitted diseases.

Women and healthcare professionals who would like to learn more about Femcon Fe, including full Prescribing Information, should visit

Source: Warner Chilcott

Recent Headlines

Statistically Significant Improvement in Excessive Daytime Sleepiness
Researcher Made Himself Guinea Pig to Test the Drug
Treatment Shorter, Less Complicated Than Typical Regimen
Zip Device Faster to Apply, Minimizes Scarring
But a ‘Serendipitous’ Finding Could Provide a Solution
New Drug Could Make Ears “Young” Again
DNA Changes May Help Predict Women at Risk
Finding Could Spur New Targeted Treatments